The first patient has been dosed in the resumed Phase 2a clinical trial of montelukast for mild to moderate…
Articles by Yedida Y Bogachkov PhD
The National Institutes of Health (NIH) awarded $2 million to investigators studying how chronic physiological stress may cause vascular changes…
Longeveron is initiating a Phase 2a clinical trial for its Lomecel-B treatment — an investigational, bone marrow-derived, medicinal signaling…
An international clinical trial for gantenerumab aimed at preventing inherited, early-onset Alzheimer’s disease is being launched at the Washington…
Acadia Pharmaceuticals intends to again request that oral Nuplazid (pimavanserin) be approved to treat hallucinations and delusions, but this…
I-Mab Biopharma announced that the first patient has been dosed in the U.S.-based Phase 1 trial of its intranasal…
The Tau Next Generation (Tau NexGen) clinical trial will now be evaluating an anti-amyloid antibody in addition to an anti-tau…
AC Immune has announced it will extend its partnership with researchers at the University of Pennsylvania to further study the mechanisms underlying…
The MassAITC project was recently launched to focus on using artificial intelligence (AI) to improve in-home care for older…
The first patient has been recruited, in Finland, for Alzinova AB’s Phase 1b clinical trial testing its ALZ-101 vaccine…